blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2097091

EP2097091 - CONJUGATE OF NATRIURETIC PEPTIDE AND ANTIBODY CONSTANT REGION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.04.2013
Database last updated on 02.07.2024
Most recent event   Tooltip26.04.2013Application deemed to be withdrawnpublished on 29.05.2013  [2013/22]
Applicant(s)For all designated states
CardioPep Pharma GmbH
Feodor-Lynen-Strasse 23
30625 Hannover / DE
[N/P]
Former [2010/03]For all designated states
Cardiopep Pharma GmbH
Feodor-Lynen-Strasse 23
30625 Hannover / DE
Former [2009/37]For all designated states
PDL BioPharma, Inc.
1400 Seaport Blvd.
Redwood City, CA 94063 / US
Inventor(s)01 / BHASKAR, Vinay
1712 Castro Street
San Francisco, CA 94131 / US
02 / DUBRIDGE, Robert Bryan
825 Holly Road
Belmont, CA 94002 / US
03 / RAMAKRISHNAN, Vanitha
825 Holly Road
Belmont, CA 94002 / US
04 / JANTZEN, Hans-Michael
350 Church Street, Apt. H
San Francisco, CA 94114 / US
 [2009/37]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2010/15]von Kreisler Selting Werner
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2009/37]Meyers, Hans-Wilhelm
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41
50462 Köln / DE
Application number, filing date07869671.320.12.2007
[2009/37]
WO2007US88404
Priority number, dateUS20060876913P21.12.2006         Original published format: US 876913 P
US2007096042719.12.2007         Original published format: US 960427
[2009/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008079995
Date:03.07.2008
Language:EN
[2008/27]
Type: A2 Application without search report 
No.:EP2097091
Date:09.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application.
[2009/37]
Search report(s)International search report - published on:US28.08.2008
(Supplementary) European search report - dispatched on:EP14.01.2010
ClassificationIPC:A61K38/00, A61K38/24, C07H21/04
[2009/37]
CPC:
C07K14/58 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P13/12 (EP); A61P31/04 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); C07K2319/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/37]
TitleGerman:KONJUGAT AUS EINEM NATRIURETISCHEN PEPTID UND DER KONSTANTEN DOMÄNE EINES ANTIKÖRPERS[2009/37]
English:CONJUGATE OF NATRIURETIC PEPTIDE AND ANTIBODY CONSTANT REGION[2009/37]
French:CONJUGUÉ COMPRENANT UN PEPTIDE NATRIURÉTIQUE ET UNE RÉGION CONSTANTE D'UN ANTICORPS[2009/37]
Entry into regional phase26.06.2009National basic fee paid 
26.06.2009Search fee paid 
26.06.2009Designation fee(s) paid 
26.06.2009Examination fee paid 
Examination procedure26.06.2009Examination requested  [2009/37]
17.08.2009Amendment by applicant (claims and/or description)
06.05.2010Despatch of a communication from the examining division (Time limit: M06)
10.11.2010Reply to a communication from the examining division
25.07.2012Despatch of a communication from the examining division (Time limit: M04)
06.12.2012Application deemed to be withdrawn, date of legal effect  [2013/22]
08.01.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/22]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.05.2010
Fees paidRenewal fee
22.12.2009Renewal fee patent year 03
28.12.2010Renewal fee patent year 04
28.12.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.12.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2005047334  (HANMI PHARM IND CO LTD [KR], et al) [X] 1-14 * abstract * * page 7, paragraph L * * page 26, line 19 - line 26 * * page 27, line 14 - line 24 * * page 28, line 6 - line 14 * * page 30, line 18 *;
 [X]WO2006107124  (HANMI PHARMACEUTICAL CO LTD [KR], et al) [X] 1-14 * abstract * * page 8, line 3 - line 19 * * page 9, line 12 - line 21 * * page 19, line 12 - line 18 * * page 24, line 7 - page 25, line 15 * * page 26, line 21 - page 27, line 7 * * page 28, line 16; claims 21-23 *;
 [XY]WO2005007809  (ALEXION PHARMA INC [US], et al) [X] 1,4-7,9-11,13 * page 21, paragraph L - page 22, paragraph 1 * * claims 27,28 * [Y] 1-14;
 [Y]US2006074009  (JAMES KENNETH D [US], et al) [Y] 1-13 * abstract * * paragraphs [0003] , [0004] , [0012] , [0015] , [0016] , [0048] , [0067] , [0080] , [0145] , [0146] , [0299] , [0301] *;
 [A]DE19535445  (BOEHRINGER MANNHEIM GMBH [DE]) [A] * the whole document * * claims 5,6 *
 [Y]  - FORSSMANN W-G ET AL, "THE RENAL URODILATIN SYSTEM: CLINICAL IMPLICATIONS", CARDIOVASCULAR RESEARCH, OXFORD UNIVERSITY PRESS, (20010815), vol. 51, no. 3, ISSN 0008-6363, pages 450 - 462, XP001098418 [Y] 14 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0008-6363(01)00331-5
International search[X]  - MITROVIC ET AL., "Haemodynamic and clinical effects of ularitidie in decompensated heart failure", EUROP. HEART JOURNAL, (2006), vol. 27, pages 2823 - 2832, XP008109844

DOI:   http://dx.doi.org/10.1093/eurheartj/ehl337
 [Y]  - KENNY ET AL., "Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natiuretic peptide and some C-receptor ligands by endopeptidase-24.11", BIOCHEMICAL JOURNAL, (1993), vol. 291, pages 83 - 88, XP008109843
 [Y]  - LOW S.C. ET AL., "Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis", HUMAN REPRODUCTION, (2005), vol. 20, no. 7, pages 1805 - 1813, XP002455704

DOI:   http://dx.doi.org/10.1093/humrep/deh896
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.